Identification of Hip BMD Loss and Fracture Risk Markers Through Population-Based Serum Proteomics: HIP BMD LOSS & FRACTURE RISK MARKERS BY POPULATION-BASED SERUM PROTEOMICS

• Published in: Journal of bone and mineral research 2017-04, Vol.32 (7)
• Main Authors: Nielson, Carrie M., Wiedrick, Jack, Shen, Jian, Jacobs, Jon, Baker, Erin S., Baraff, Aaron, Piehowski, Paul, Lee, Christine G., Baratt, Arie, Petyuk, Vladislav, McWeeney, Shannon, Lim, Jeong Youn, Bauer, Douglas C., Lane, Nancy E., Cawthon, Peggy M., Smith, Richard D., Lapidus, Jodi, Orwoll, Eric S.
• Format: Article
• Language: English
• Subjects: 60 APPLIED LIFE SCIENCES; BASIC BIOLOGICAL SCIENCES; Environmental Molecular Sciences Laboratory
• ISSN: 0884-0431; 1523-4681
• DOI: 10.1002/jbmr.3125

Accelerated bone loss significantly increases the risk of osteoporosis and fracture. The mechanisms underlying bone loss remain incompletely understood, and there are few available biomarkers. We utilized a novel proteomics approach to identify serum peptides and proteins associated with bone loss in 1967 older men who were randomly chosen from the Osteoporotic Fracture in Men Study (MrOS study) (age ≥ 65 yrs). Men had 2-3 measures of femoral neck BMD over an average follow-up of 4.6 years. Change in BMD was estimated and then categorized into three groups: maintained BMD (n=453), expected loss (n=1185) and accelerated loss (n=237). A liquid chromatography–ion mobility separation-mass spectrometry (LC-IMS-MS) proteomics platform was used to identify and quantify peptides from serum proteins. The whole cohort was randomly divided into discovery (N= 960) and validation (N= 915) sub-cohorts. Linear regression models and a random forest approach were used to discover differentially abundant individual peptides and a proteomic signature that distinguished individuals with accelerated bone loss from those who maintained BMD. Network analyses were performed using the MetaCore knowledgebase. We identified 12 peptides that were associated with BMD loss in both discovery (P< 0.1 FDR) and replication sub-cohorts (P